roche glp-1 drug produces “robust” weight loss in late-stage obesity trial | News Baseline, Roche, Intellia, Eli Lilly:

In addition, when neuronal activity in certain brain regions becomes extremely high, and the energy demand exceeds the rate of aerobic glucose oxidation, neurons rapidly take up and use lactate

As a result, plans will want to address these coverage issues with their PBMs and tighten up drug utilization controls or they will see growing expenses from these new GLP-1 drugs under their pharmacy benefit program

In the future, we expect that directed evolution of PLD PMF will enable development of PLDs with activities tuned to make different lipid products to realize the promise of PLDs as the starting point for more general phospholipid editors beyond PA signaling

Cannot redeclare control with same name "grid_3_qv_arrow_heading"

Portal triads and central veins may be present

All of the above properties have been observed in laboratory studies not conducted on humans, and are intended for informational purposes only